Clinical Development of Immunotherapy for Small Cell Lung Cancer

Clinical Development of Immunotherapy for Small Cell Lung Cancer

Small cell lung cancer (SCLC), which accounts for about 15% of lung cancer cases, is an aggressive disease characterized by rapid growth and early widespread metastasis. Despite sensitive to chemotherapy and radiotherapy, SCLC is vulnerable to get resistant and has high recurrence rates. In recent y...

Full description

Bibliographic Details
Main Authors: Tao YU, Diansheng ZHONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-12-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Immunotherapy
Clinical development
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.12.10

Similar Items

Similar Items